Else Nutrition Aims to Disrupt Baby and Child Nutrition Forever, with Plant-Based, Non-Dairy/Non-Soy Nutrition

VANCOUVERBritish ColumbiaFeb. 25, 2020 /PRNewswire/ — Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) (“Else Nutrition”, “Else” or the “Company”), a game-changing developer and marketer of clean-ingredient, plant-based nutrition products, is launching its first commercial product this spring in the U.S. – following nearly seven years of research and development.  It’s a next-generation, 100 percent plant-based, organic toddler nutrition made with a proprietary formulation of almonds, buckwheat, and tapioca. The globally-patented, toddler nutritional drink (toddler formula) tastes great, contains zero dairy or soy, and is free of gluten, hormones, antibiotics, palm oil, and corn syrups.

Else Nutrition Aims to Disrupt Baby and Child Nutrition with Plant-Based, Non-Dairy/Non-Soy Formulas

The startup, founded by infant nutrition veterans, fills a market gap, with plant-based toddler nutrition (for ages 12-36 months) made with clean, whole ingredients from whole foods. The simple-to-use powder is the first in a planned line of whole-meal nutrition products from Else for children of ages ranging from infant to teens.

“As a mother, I know how passionate parents are to ensure that their children get all the nutrients they need for fundamental growth and development. We are providing a solution for millions of parents worldwide who are looking to change the way they feed their kids by offering a clean, safe, and nutritious, plant-based nutrition option. We’ve heard from thousands of parents worldwide that there’s a need for something else – a real viable alternative,” said Hamutal Yitzhak, Co-Founder and CEO of Else Nutrition Holdings Inc. Else is based in Tel Aviv, Israel, and started trading on the Toronto stock exchange last June.

For nearly 120 years, the infant and toddler formula markets have been based on dairy and soy protein sources. Else prides itself on offering a real alternative. Else provides complete nutrition made from simple ingredients and a clean process. Else is plant-based, sustainable, organic, and vegan.

The plant-based toddler nutrition drink offers a full essential amino acid profile, and is a clean non-GMO source of protein, fully meeting the strictest regulatory requirements. Else’s ‘beyond organic’ disruptive manufacturing processes include the transformation of whole plants, without using highly-processed extracts or derivatives, chemicals or high-fructose corn syrup.

Else’s toddler nutrition will be sold initially in powder form, ready to drink in just seconds. It will be available online at elsenutrition.com for pre-ordering, with official sales starting later in Q2 at the same e-Store. Sales will also roll-out via Amazon, and at select specialty retailers by the summer of 2020. The suggested retail price is $35 for a 23.2 oz. powder canister.

Else’s leaders and founders have held executive positions with the likes of Abbott Laboratories, and Materna (a leading baby formula producer, acquired by Nestlé). The company was born out of the personal quest of a caring grandfather seeking to find a solution for his granddaughter who suffered from severe baby formula allergies. The company’s vision is to transform feeding for babies and families worldwide. Else aims to launch its plant-based infant formula in the coming years.  

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) GH ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, 100% plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition won the “2017 Best Health and Diet Solutions’ award at the Global Food Innovation Summit in Milan. The holding company, ELSE Nutrition Holdings Inc, is a publicly-traded company, listed as (TSX.V:BABY), as part of the TSX Venture Exchange and as (OTCQB:BABYF) as part of the NY OTC QB Exchange. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

SOURCE Else Nutrition Holdings Inc.

Please See Disclaimer


Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2)The Article was issued on behalf of a third party, Else Nutrition Holdings Inc. Market Jar Media Inc. has or expects to receive thirty-nine thousand, four hundred and sixty Canadian dollars from Else Nutrition Holdings Inc.’s agency of record Native Ads Inc. for 26 days (20 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.